Assembly Biosciences (NQ: ASMB )

4.480 USD UNCHANGED

Streaming Delayed Price Updated: 5:43 AM EST, Mar 8, 2021 Add to My Watchlist

Price and Volume

Volume	426
Open	4.480
Bid (Size)	4.500 (2)
Ask (Size)	4.630 (2)
Prev. Close	4.480
Today's Range	4.480 - 4.500
52wk Range	4.305 - 27.84
Shares Outstanding	20,550,718
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 05, 2021

Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination Therapy for the Treatment of Chronic Hepatitis B Virus

February 26, 2021

Performance

YTD	-25.83%	-25.83%
1 Month	-27.15%	-27.15%
3 Month	-26.86%	-26.86%
6 Month	-74.89%	-74.89%
1 Year	-74.44%	-74.44%

More News

Assembly Biosciences Reports Fourth Quarter and Year End 2020 Financial Results and Recent Highlights

February 25, 2021

Assembly Biosciences Updates Pipeline Strategy, Focusing on Finite and Curative Therapies for Chronic Hepatitis B Virus Infection

February 25, 2021

Assembly Bio Announces Upcoming Investor Events

February 19, 2021

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 05, 2021

Assembly Biosciences to Wind-Down Microbiome Program

December 08, 2020

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 04, 2020

Assembly Biosciences Appoints Nicole S. White, PhD, as Senior Vice President of Pharmaceutical Development and Manufacturing

November 17, 2020

Assembly Bio/Arbutus Bio Start Testing Vebicorvir/AB-729 Triplet Therapy In HBV Infection

February 26, 2021

Assembly Biosciences Foregoes Vebicorvir Registration Studies For Chronic Suppressive Therapy

February 26, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.